Solid Biosciences SLDB
NASDAQ SLDB
$6.82 -0.16 (-2.29%)
As of: Oct 2, 2026 · 2:46 PM EDT

Solid Biosciences (SLDB) Return on Assets [ROA] (2018 - 2026)

Updated

Solid Biosciences (SLDB) recorded Return on Assets [ROA] of -49.11% in Q2 2026, down 1.85 percentage points from -47.25% a year earlier but up 9.41 percentage points from the prior quarter.

Analysis

Solid Biosciences (SLDB) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, Solid Biosciences reported Return on Assets [ROA] of -82.78%, down 12.24 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for three straight years, with a five-year change of -18.48 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -70.53% in FY2024 (-25.37 pp), -45.16% in FY2023 (-10.26 pp), -34.91% in FY2022 (+0.87 pp) and -35.78% in FY2021 (+28.52 pp).
  • Quarterly Return on Assets [ROA] has ranged from -68.84% in Q4 2025 to -29.11% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] has declined for seven consecutive quarters, with an average year-over-year change of -6.36 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 171.51 percentage points in Q3 2021, against a drop of 16.41 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -58.52% (Q1 2026), -68.84% (Q4 2025) and -57.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Solid Biosciences 1.04 Bn 1.04 Bn - -49.11%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -49.11%
Mar 31, 2026 -58.52%
Dec 31, 2025 -68.84%
Sep 30, 2025 -57.42%
Jun 30, 2025 -47.25%
Mar 31, 2025 -52.46%
Dec 31, 2024 -62.27%
Sep 30, 2024 -46.27%
Jun 30, 2024 -37.81%
Mar 31, 2024 -43.64%
Dec 31, 2023 -54.92%
Sep 30, 2023 -46.65%
Jun 30, 2023 -41.56%
Mar 31, 2023 -37.04%
Dec 31, 2022 -38.67%
Sep 30, 2022 -45.52%
Jun 30, 2022 -41.83%
Mar 31, 2022 -36.65%
Dec 31, 2021 -29.99%
Sep 30, 2021 -29.11%
API Access

Solid Biosciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SLDB&period=max&api_key=YOUR_API_KEY